Virtual Reality and Treadmill Training for Stroke
(PROVE Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new method to improve thinking skills and walking ability in stroke survivors. One group will use virtual reality combined with a special treadmill (omnidirectional virtual reality and treadmill training), while the other group will perform traditional exercises. The researchers aim to determine if the virtual reality method can more effectively enhance balance, walking, and overall quality of life. Individuals who had a stroke more than six months ago and have difficulty walking may be suitable for this trial. Participants should live near Halifax, Nova Scotia, and be able to exercise for at least 15 minutes without major health or vision issues affecting walking.
As an unphased trial, this study provides a unique opportunity to explore innovative rehabilitation methods that could enhance recovery and quality of life.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this virtual reality and treadmill training is safe for stroke survivors?
Research has shown that using virtual reality with treadmill exercises is generally safe and well-received. Studies with similar setups have found that stroke survivors often walk faster and feel more motivated, with no major side effects. Although detailed safety data from large groups is lacking, virtual reality has shown promise in addressing various health issues. This suggests it could be safe for stroke recovery as well. Before joining a trial, discussing potential risks and benefits with a doctor is important.12345
Why are researchers excited about this trial?
Researchers are excited about using omnidirectional virtual reality and treadmill training for stroke rehabilitation because it offers a new, immersive way to engage patients. Unlike traditional physiotherapy that typically involves repetitive, unidirectional treadmill exercises, this method uses virtual environments to simulate real-world scenarios, which could enhance motor learning and engagement. Additionally, the ability to move in multiple directions can better mimic everyday activities, potentially leading to more effective recovery of mobility and coordination for stroke survivors.
What evidence suggests that this trial's treatments could be effective for stroke survivors?
Research has shown that virtual reality (VR) can aid stroke survivors by enhancing both physical abilities and mental well-being. Studies have found that VR therapy significantly increases walking speed and distance, as well as overall movement. It also boosts motivation and supports neuroplasticity, which aids recovery. In this trial, participants in the Omni-VR group will train using omnidirectional virtual reality and treadmill training, which has proven especially effective for those more than six months post-stroke. This suggests that VR and treadmill training could be a promising method for stroke recovery.46789
Are You a Good Fit for This Trial?
This trial is for chronic stroke survivors who had a stroke at least 6 months ago, can walk with minimal assistance, have walking limitations, moderate or severe cognitive impairment but can still exercise for at least 15 minutes. They must live near Halifax and not have other health issues affecting balance or vision.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo 45-minute training sessions 3 times per week for 12 weeks using either omnidirectional virtual reality and treadmill training or traditional exercise program
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Omnidirectional Virtual Reality and Treadmill Training
Find a Clinic Near You
Who Is Running the Clinical Trial?
Nova Scotia Health Authority
Lead Sponsor
Brain Canada
Collaborator